Head & Neck Cancer Treatment in Hyderabad
Reviewed May 2026 · Dr. Madhav Danthala
India has one of the highest rates of oral cancer globally — driven mostly by tobacco and gutka. HPV-related throat cancers are also rising. Dr. Madhav Danthala provides treatment planning, chemotherapy, targeted therapy, and immunotherapy for head and neck cancers at KIMS-Sunshine Hospitals, Begumpet, and Peoples Polyclinic, Manikonda.
When to See a Doctor
Most mouth ulcers heal in two weeks. The pattern that matters is anything that does not.
Dr. Danthala's Approach
Head and neck cancer treatment requires multidisciplinary coordination. Three principles shape every consultation.
-
HPV status first
Every oropharyngeal cancer is tested for HPV at diagnosis — it changes prognosis and may guide de-escalated treatment.
-
Multidisciplinary planning
Care is coordinated across head-and-neck surgery, radiation oncology, and medical oncology — with shared decision-making at every step.
-
Clear, structured communication
Every consult ends with a written summary of the plan, including expected impact on speech, swallowing, and quality of life.
Treatment Options
Head and neck cancer treatment depends on site, stage, and HPV status. Quality of life — speech, swallowing, appearance — is part of every plan. Below are the major modalities, almost always combined.
Resection with reconstruction; TORS for selected oropharyngeal
For oral cavity cancers, surgical resection followed by reconstruction (often with free flaps) is the standard. Neck dissection is usually included to remove nodal disease. Transoral robotic surgery (TORS) has changed the landscape for selected oropharyngeal cancers, allowing minimally invasive resection with preserved function. Elective tracheostomy may be needed for swelling management.
IMRT, often concurrent with chemotherapy
Intensity-modulated radiation therapy (IMRT) over 6-7 weeks is foundational, especially for laryngeal preservation. For locally advanced disease, concurrent chemoradiation with cisplatin is the standard. For HPV-positive oropharyngeal cancers, de-escalated radiation protocols are being studied to reduce long-term toxicity. Speech-and-swallowing therapy starts before treatment and continues afterward.
Cisplatin, cetuximab, immunotherapy for advanced disease
Cisplatin is the standard radiosensitiser. Cetuximab (anti-EGFR) is an alternative for cisplatin-ineligible patients. For recurrent or metastatic disease, pembrolizumab and nivolumab have changed outcomes — pembrolizumab + chemotherapy is the standard first-line for PD-L1+ disease. EGFR-targeted therapy and clinical trials of HPV-targeted approaches continue to expand the menu.
Speech, swallowing, dental, nutrition, prosthodontic
Head and neck cancer treatment routinely affects swallowing, speech, taste, and dental health. A multidisciplinary team — speech-language therapists, dietitians, dental oncologists, prosthodontists, and rehabilitation specialists — works alongside surgical, medical, and radiation oncology throughout treatment. Pre-treatment dental work and feeding-tube planning are part of the standard workup.
Treatment is shaped by site, stage, HPV status, and quality-of-life priorities. The list above is the menu. The right plan is built with the patient in the room.
Frequently Asked Questions
What are the warning signs of oral cancer?
Any non-healing mouth ulcer or sore that persists more than three weeks. White or red patches inside the mouth, painless neck lump, persistent hoarseness, difficulty swallowing, or unexplained ear pain on one side are also warning signs.
Does gutka cause oral cancer?
Yes. Gutka, paan, khaini, and other smokeless tobacco products are major causes of oral cancer in India. They cause oral submucous fibrosis that progresses to cancer over years. Stopping use significantly reduces risk.
What is HPV-related oropharyngeal cancer?
Some throat cancers — particularly tonsils and base of tongue — are caused by HPV infection. HPV-positive cancers behave differently from tobacco-related, often respond better to treatment, and may benefit from de-escalated protocols.
Should children get the HPV vaccine?
Yes. Given between ages 9 and 14 (catch-up to 26), the HPV vaccine prevents the strains most strongly linked to cervical, anal, and oropharyngeal cancers. The same vaccine that prevents cervical cancer in women also prevents HPV-related throat cancers in men and women. Tobacco-driven oral and laryngeal cancers share the risk profile of lung cancer — counselling for either should cover both.
What does treatment involve?
Early-stage: surgery or radiation alone. Locally advanced: combined chemoradiation. Recurrent or metastatic: immunotherapy (pembrolizumab, nivolumab) and targeted therapy (cetuximab) plus chemotherapy.
About Dr. Madhav Danthala
Dr. Madhav Danthala is a medical oncologist and hemato-oncologist practising at KIMS-Sunshine Hospitals, Begumpet and Peoples Polyclinic, Manikonda, Hyderabad. His clinical interests span breast, lung, gastrointestinal, gynaecologic, and head & neck cancers, with a focus on subtype-led treatment planning, second opinions, and shared decision-making. He has trained at premier oncology institutes and performed 300+ stem cell transplants.
Trusted guidelines & further reading
- ESMO — Cancer Guides for Patients European Society for Medical Oncology patient guides — freely accessible, evidence-based.
- ASCO / Cancer.Net — Head & Neck Cancer American Society of Clinical Oncology patient education portal.
- NCI / Cancer.gov — Head & Neck Cancers US National Cancer Institute clinical treatment summaries.
From our blog
- The Two-Oncologist Rule: When to Get a Second Opinion For HPV-positive oropharyngeal cancers, treatment de-escalation conversations are a strong reason for a second opinion.
- When Symptoms Are Mistaken for Something Else Tobacco-related cancers — oral, laryngeal, lung — share a diagnostic-delay problem worth understanding.